PONTARA, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.175
EU - Europa 451
AS - Asia 401
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 5.031
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.172
CN - Cina 263
VN - Vietnam 121
SE - Svezia 101
FI - Finlandia 100
IT - Italia 93
DE - Germania 55
GB - Regno Unito 39
UA - Ucraina 17
NL - Olanda 15
BE - Belgio 10
IE - Irlanda 6
IN - India 4
EU - Europa 3
FR - Francia 3
JP - Giappone 3
TR - Turchia 3
CA - Canada 2
DK - Danimarca 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BG - Bulgaria 1
CH - Svizzera 1
HK - Hong Kong 1
HU - Ungheria 1
IQ - Iraq 1
IR - Iran 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.031
Salva come PNG Salva come JPEG
Città #
Fairfield 780
Chandler 440
Woodbridge 390
Ashburn 338
Houston 314
Cambridge 278
Seattle 271
Wilmington 243
Ann Arbor 230
Jacksonville 118
Dong Ket 117
Beijing 90
Princeton 90
San Diego 72
Padova 48
Medford 47
Nanjing 47
Helsinki 39
Roxbury 33
Boardman 29
Des Moines 23
New York 15
Changsha 14
Shenyang 14
Washington 14
Norwalk 13
Hebei 11
Jiaxing 11
London 9
Hefei 8
Waanrode 8
Milan 7
Nanchang 7
Redwood City 7
Dublin 6
Borås 5
Kunming 5
Florence 4
Ho Chi Minh City 4
Indiana 4
Tianjin 4
Chicago 3
Dearborn 3
Guangzhou 3
Istanbul 3
Kilburn 3
Los Angeles 3
Pune 3
Southwark 3
Tappahannock 3
Vicenza 3
Zhengzhou 3
Agrigento 2
Bethel Park 2
Brussels 2
Chiswick 2
Dallas 2
Falls Church 2
Fuzhou 2
Hangzhou 2
Kharkiv 2
Ospedaletto Euganeo 2
Parma 2
Ponte di Piave 2
Rockville 2
Savona 2
Simi Valley 2
Stockholm 2
Tomblaine 2
Yellow Springs 2
Agordo 1
Anaheim 1
Asir 1
Atlanta 1
Auckland 1
Bratislava 1
Budapest 1
Buffalo 1
Carmignano Di Brenta 1
Carol Stream 1
Chengdu 1
Chongqing 1
Copenhagen 1
Cormeilles-en-Parisis 1
Denver 1
Dubai 1
Enschede 1
Ferentino 1
Frankfurt am Main 1
Geislingen an der Steige 1
Ichibacho 1
Jinan 1
Jinhua 1
Lisbon 1
Livorno 1
Luxembourg 1
Lyngby 1
Macao 1
Malo 1
Manila 1
Totale 4.306
Salva come PNG Salva come JPEG
Nome #
Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease. 142
Type IIB von Willebrand Factor induces phospholipase A2 activation and cytosolic Ca2+ increase in platelets 120
Haemostatic patterns and bleeding scores of a genetically characterised Italian family with combined haemophilia A and type 1 von Willebrand disease 120
New insight into the Hypercoagulability of Cushing's Syndrome 117
A new L1446P mutation is responsible for impaired von Willebrand factor synthesis, structure, and function. 116
Usefulness of the Total Thrombus-Formation Analysis System (T-TAS) in the diagnosis and characterization of von Willebrand disease 114
Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor 111
Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease. 110
Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. 108
The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity 107
Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura. 105
von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease. 104
Severe, recessive type 1 is a discrete form of von Willebrand disease: The lesson learned from the c.1534-3C>A von Willebrand factor mutation 101
von Willebrand factor abnormalities in aortic valve stenosis:pathophysiology and impact on bleeding. 97
Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns 94
Acquired factor VIII:C inhibitor in a patient with Sjögren's syndrome: successful treatment with steroid and immunosuppressive therapy. 92
Higher and lower active circulating VWF levels: different facets of von Willebrand disease 90
Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series. 90
Hypercortisolism and pregnancy upregulate von Willebrand factor through different mechanisms: report on a pregnant patient with Cushing's syndrome. 89
A novel von Willebrand factor mutation (11372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis 85
EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA. 84
Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia. 83
C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor 82
Inhibitory effect of prostacyclin and nitroprusside on type IIB von Willebrand factor-promoted platelet activation. 81
Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay. 81
Urokinase-type plasminogen activator release after DDAVP in von Willebrand disease: different behaviour of plasminogen activators according to the synthesis of von Willebrand factor. 80
Platelet aggregation induced by plasma from type IIB von Willebrand's disease patients is associated with an increase in cytosolic Ca2+ concentration. 80
Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers. 79
Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity? 78
A common ancestor more than 10,000 years old for patients with R854Q-related type 2N von Willebrand's disease in Italy. 75
Type I Padua: a new variant of von Willebrand's disease. 74
Which assay is the most suitable to investigate von Willebrand factor functional activity? 74
Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease. 74
Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation. 73
Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 73
The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications. 72
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. 72
First report of combined factor VII Padua defect and von Willebrand's disease due to casual association of the two defects. 71
Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content. 71
Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization. 70
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. 69
Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis. 69
Two novel mutations (Pro864His, Val867Glu) causing type 2A von Willebrand disease and affecting a single restriction site in exon 28. 67
On the release of von Willebrand factor from endothelial cells after venous occlusion. 67
Demonstration that venous occlusion fails to release von Willebrand factor multimers. 66
Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors. 66
Combined exon skipping and cryptic splice activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 65
A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers. 65
Microsatellite (GT)(n) repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions. 65
Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome. 64
Plasma and platelet von Willebrand factor abnormalities in patients with uremia: lack of correlation with uremic bleeding. 59
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor 58
Type 2N von Willebrand disease due to Arg91Gln substitution and a cytosine deletion in exon 18 of the von Willebrand factor gene. 55
On the discrepant post-DDAVP increase of FVIII:C and von Willebrand factor in some patients with severe von Willebrand's disease. 52
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 49
DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor. 47
An apparent silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease. 45
Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor. 44
Preliminary hemocompatibility assessment of an innovative material for blood contacting surfaces 44
Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodies 44
Discrepant increase in factor VIII: C and von Willebrand factor after DDAVP infusion in a patient with variant von Willebrand's disease. 43
Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion. 40
Identifying carriers of type 2N von Willebrand disease: procedures and significance. 38
Serum Anti-Heart and Anti-Intercalated Disk Autoantibodies: Novel Autoimmune Markers in Cardiac Sarcoidosis 38
Combined hemophilia A and type 2 von Willebrand's disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor. 36
DDAVP infusion: a possible useful tool in the diagnosis of the haemophilia A carrier state. 32
A Machine-Learning Model for the Prognostic Role of C-Reactive Protein in Myocarditis 31
Fulminant Myocarditis: When One Size Does Not Fit All – A Critical Review of the Literature 9
Anti-phosphatidyl-serine/prothrombin antibodies (aPS/PT) in isolated lupus anticoagulant (LA): is their presence linked to dual test positivity? 3
Totale 5.069
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.295
article - articoli 17.295
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.590
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019428 0 0 0 0 0 0 0 0 0 0 225 203
2019/20201.104 191 35 19 66 129 80 106 145 117 93 75 48
2020/2021728 35 32 19 65 27 60 42 56 98 78 64 152
2021/2022984 49 105 152 64 12 70 72 104 23 31 145 157
2022/2023832 150 105 11 114 118 115 2 54 95 7 54 7
2023/2024353 23 50 62 42 46 55 39 17 7 11 1 0
Totale 5.069